SEC ownership of GENMAB A/S

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001434265.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

Paradigm Biocapital Advisors LP

Comparable rows

2/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001434265
Issuer location
1253 Copenhagen K, Denmark

Ownership snapshot

Top shareholders of GENMAB A/S (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
Paradigm Biocapital Advis...
Comparable rows
2/50
Latest evidence
30 Jun 2026
13F 13D/G Lead comparable stake: 5.6% 48 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 5.6%.

2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 2
BlackRock, Inc. 5.6%
ORBIS INVESTMENT MANAGEMENT LTD 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
5.6%
from 13D/G
$128,319,300
4,671,252 shares
30 Jun 2026
ORBIS INVESTMENT MANAGEMENT LTD
13D/G
5.3%
3,320,695 shares
$0 30 Jun 2026
Paradigm Biocapital Advisors LP
13F
Company
13F
class O/S missing
$360,767,109
13,133,131 shares
30 Jun 2026
Orbis Allan Gray Ltd
13F
Company
13F
class O/S missing
$312,283,383
11,368,161 shares
30 Jun 2026
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
class O/S missing
$231,942,050
8,644,877 shares
30 Jun 2026
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
class O/S missing
$188,581,550
6,865,000 shares
30 Jun 2026
Deep Track Capital, LP
13F
Company
13F
class O/S missing
$155,205,500
5,650,000 shares
30 Jun 2026
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
13F
class O/S missing
$136,672,150
4,975,324 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for GENMAB A/S

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .